DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Packaging Equipment – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

With the World Awaiting Vaccine Supply for 7.5 Billion People, the Drug Packaging Market Remains Optimistic With a 13.2% Spike in Revenues

The global market for Pharmaceutical Packaging Equipment is expected to witness a 13.2% spurt in revenues for the year 2020 and thereafter reach US$15.2 billion by the year 2027, trailing a post COVID-19 CAGR of 9.3% over the analysis period 2020 through 2027.

Despite the optimistic outlook for the market, the pharmaceutical industry is not without its share of challenges. The industry is witnessing disruptions in supply of active materials and ingredients, with production dependent on raw materials from China impacting most countries. The rude shock rendered by the pandemic has awakened the focus on self-sufficiency in production supply chain. Drug R&D, scheduled approvals and launches & routine production of non-COVID drugs are showing signs of being impacted.

As a result of lockdowns and consumption of healthcare resources for COVID-19, TB & its deadly allies like HIV & malaria are making a comeback. Over 7 million additional cases of TB are forecasted by the end of 2020. Drug production faces the pressure of pent-up demand, and challenges in scaling production to meet the increased demand. In a fairly mixed outlook, drug packaging equipment will benefit from the search for drugs, therapies & vaccines for COVID-19 & post virus focus on public health & innovative drug development. (Read more…)

Several companies have started to provide antiviral, sterile packaging to mitigate concerns associated with the viral exposure. These solutions are intended to protect frontline workers engaged in dealing with the rapidly increasing cases of COVID-19. The pandemic has not only pushed demand for healthcare packaging such as pumps, rigid plastic and flexible blister foils, but has also increased the risk of transmission of the virus through pharmaceutical packaging surfaces.

Mounting concerns regarding viral exposure is largely due to the ability of the virus to survive on packaging surfaces for longer periods. These concerns are poised to benefit antiviral, sterile packaging formats. Plastics, against this backdrop, are emerging as a perfect material for antiviral and sterile packaging. Based on its high versatility and barrier properties, plastic is anticipated to emerge as the preferred option for these packaging solutions.

Moreover, antiviral biopolymers, mainly products reinforced with specific active drug components, are anticipated to witness immense popularity owing to their eco-friendly nature and low toxicity. These products present an effective solution to reduce the contamination risk and ensure handling safety. Several companies are also betting on NO2-based sterilization technology for achieving product differentiation. The technology offers benefits of ultra-low temperature process, low pressure requirements and faster cycle times. In addition, plastic presents an ideal solution for ensuring longer shelf life of pharmaceutical products, which is slated to benefit the packaging material during the pandemic.

In support of the world’s focus on development of COVID-19 vaccine, pharmaceutical packaging market is also scaling up operations to keep pace with the ongoing efforts in the space. Companies engaged in development of COVID-19 vaccines are signing agreements with packaging companies for manufacturing syringes and vials to package COVID-19 vaccine.

Moderna for instance announced a collaborative deal with Catalent in June 2020 for providing vial filling and packaging for initial batch of 100 million doses of vaccine from its US facility in Indiana. The company is expected to produce around 500 million to 1 billion doses annually, starting in 2021 from its US-based production facility, through a strategic partnership with Lonza, enhancing the need for packaging solutions. Presently, around 142 experimental vaccines are under studies, focusing on diverse technologies, to efficiently assess clinical outcomes across board.

Irrespective of the diverse platforms, the development haste is all set to augur well for the production of vaccine in the near term. About 13 vaccines have entered human trials to test the safety and efficacy of the vaccine on healthy volunteers, while 129 are in pre-clinical animal trial studies.

Moderna, AstraZeneca, CanSino Biologics, and Pfizer are expected to be released in the first wave during second half of 2020 and first quarter of 2021. The second wave will see Johnson & Johnson, GlaxosmithKline/Sanofi in the second half of 2021.

The production of vaccines would start even before the regulatory approval from third quarter of 2020. Commercial availability of the vaccine would start between fourth quarter 2020 to early 2021.

Scaling up manufacturing facilities, growing global efforts in terms of non-profit public-private partnerships ensuring equitable access to vaccine supplies, greater international collaboration for mapping safety data and vaccination protocols, and strategic financing are all set to boost the prospects of successful development and utilization of COVID-19 vaccine in the near term.

Competitors identified in this market include, among others:

• Accutek Packaging Equipment Companies, Inc.
• ACG Worldwide Pvt., Ltd.
• IMA SpA
• Korber AG
• Marchesini Group SpA
• Mg2 Srl
• MULTIVAC Sepp Haggenmuller SE & Co. KG
• Optima Packaging Group GmbH
• Robert Bosch GmbH
• Romaco Pharmatechnik GmbH
• Uhlmann Group
• Vanguard Pharmaceutical Machinery, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• COVID-19 Impact on Pharmaceutical Packaging Market
• COVID-19 to Restructure the Pharmaceutical Supply Chain Management
• Pharmaceutical Companies Devise Innovative Strategies for Streamlining Supply Chain Networks
• Pharmaceutical Packaging Players Gear Up with Sterile, Antiviral Packaging to Deal with COVID-19 Challenge
• Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand for Packaging Products, Propel Growth in Packaging Equipment
• A Prelude to Pharmaceutical Packaging
• An Introduction to Pharmaceutical Packaging Equipment
• Global Pharmaceutical Packaging Equipment Market: Prospects & Outlook
• Advancements in Pharmaceutical & Biopharmaceutical Industries Fuel Growth Packaging Equipment Market
• Primary Packaging Equipment Segment Leads Market
• Liquids Packaging Equipment Dominates Global Market
• Europe Continues to Rein Global Pharmaceutical Packaging Equipment Market
• Competition
• Packaging Equipment Providers Rise Up to Address Evolving Needs and Challenges Faced by Pharmaceutical Industry

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Strong Rise in Pharmaceutical Sales to Drive Demand for Glass Packaging Solutions
• Rapid Growth of Generic Drugs Drives Demand for Pharma Packaging Equipment
• Increasing Significance of Biologic Drugs Fuels Innovations in Packaging and Delivery Techniques, Supporting Demand for Packaging Equipment
• Increasing Sales of OTC Drugs Presents an Opportunity for Pharma Packaging Equipment Makers
• Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
• Market Poised to Benefit from the Rapid Growth of Pharmaceutical Contract Manufacturing Activity
• Contract Packaging Trend Augurs Well for the Pharma Packaging Equipment Market
• With Emerging Economies Emerging as Hubs of Pharma Manufacturing Activity, Growth Potential in Store for Equipment Companies
• Trends in Pharmaceutical Sector Drive the Need for Collaboration between Industry and Equipment Providers
• OEE Makes Way into the Pharma Sector
• Serialization Drives New Design Developments in Pharma Sector
• Blister Packaging: The Mainstay of Pharmaceutical Packaging
• Blister Packaging on Rise in the Pharmaceutical Sector
• Increasing Use of Blow/Fill/Seal Technology in Pharmaceutical Packaging Applications
• Demand Remains Consistent for Aseptic & Sealing Equipment in Pharmaceutical Industry
• Rise of Smart Packaging in Pharmaceutical Sector Influences Equipment Demand
• Demand Rises for Integrated and Flexible Packaging Equipment in Pharma Industry
• Automated Packaging Equipment Support Market Growth
• Labeling & Serialization Equipment Segment Benefits from Increased Focus on Preventing Counterfeiting of Drugs
• Equipment for Small Batch Production & Research Purposes Find Favor
• Evolving Technologies and Trends Impact Growth in Pharmaceutical Manufacturing & Packaging Equipment Market
• Shift Towards Specialized Therapies and Biopharmaceuticals Influences Market
• Rising Demand for Equipment with Complex, Integrated Capabilities
• Equipment Manufacturers Striving to Address Major Industry Challenges
• Increasing Use of Robots
• Evolving and Complex Drug Formulations Lead to Packaging Equipment Innovations
• Biopharmaceuticals Drive Innovations in Pharma Packaging Equipment Market
• Pharmaceutical Packaging Equipment Vendors Bet on Innovations to Stay Afloat
• Persistent Increase in Pharmaceutical R&D Bodes Well for Packaging Equipment Manufacturers
• Strict Regulatory Standards for Packaging & Need to Eliminate Counterfeit Products Influence Equipment Development
• Regulatory Uncertainty Makes Compliance Challenging
• Inclination Towards Refurbished Equipment Emerges as a Threat to Pharma Packaging Equipment Market

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

• GEOGRAPHIC MARKET ANALYSIS
• UNITED STATES
• Pharmaceutical Packaging Emerges as a Promising Category in the US Packaging Machinery Market
• Validation Compliance of Machinery to Gain Importance
• Market Analytics
• CANADA
• JAPAN
• CHINA
• China’s Drug Contract Manufacturing Augurs Well for Packaging Equipment Makers
• Market Analytics
• EUROPE
• Europe Pharmaceutical Packaging Market: A Prelude
• Market Analytics
• FRANCE
• GERMANY
• ITALY
• UNITED KINGDOM
• SPAIN
• RUSSIA
• REST OF EUROPE
• ASIA-PACIFIC
• AUSTRALIA
• INDIA
• Indian Pharmaceutical Equipment Market: Poised for Growth
• India’s Emergence as a Hub of Pharmaceutical Manufacturing Supports Growth in Packaging Equipment Market
• Market Analytics
• SOUTH KOREA
• REST OF ASIA-PACIFIC
• LATIN AMERICA
• BRAZIL
• MEXICO
• REST OF LATIN AMERICA
• MIDDLE EAST
• AFRICA

IV. COMPETITION

• Total Companies Profiled: 98

For more information about this report visit https://www.researchandmarkets.com/r/yi89u7

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Packaging Equipment – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

With the World Awaiting Vaccine Supply for 7.5 Billion People, the Drug Packaging Market Remains Optimistic With a 13.2% Spike in Revenues

The global market for Pharmaceutical Packaging Equipment is expected to witness a 13.2% spurt in revenues for the year 2020 and thereafter reach US$15.2 billion by the year 2027, trailing a post COVID-19 CAGR of 9.3% over the analysis period 2020 through 2027.

Despite the optimistic outlook for the market, the pharmaceutical industry is not without its share of challenges. The industry is witnessing disruptions in supply of active materials and ingredients, with production dependent on raw materials from China impacting most countries. The rude shock rendered by the pandemic has awakened the focus on self-sufficiency in production supply chain. Drug R&D, scheduled approvals and launches & routine production of non-COVID drugs are showing signs of being impacted.

As a result of lockdowns and consumption of healthcare resources for COVID-19, TB & its deadly allies like HIV & malaria are making a comeback. Over 7 million additional cases of TB are forecasted by the end of 2020. Drug production faces the pressure of pent-up demand, and challenges in scaling production to meet the increased demand. In a fairly mixed outlook, drug packaging equipment will benefit from the search for drugs, therapies & vaccines for COVID-19 & post virus focus on public health & innovative drug development. (Read more…)

Several companies have started to provide antiviral, sterile packaging to mitigate concerns associated with the viral exposure. These solutions are intended to protect frontline workers engaged in dealing with the rapidly increasing cases of COVID-19. The pandemic has not only pushed demand for healthcare packaging such as pumps, rigid plastic and flexible blister foils, but has also increased the risk of transmission of the virus through pharmaceutical packaging surfaces.

Mounting concerns regarding viral exposure is largely due to the ability of the virus to survive on packaging surfaces for longer periods. These concerns are poised to benefit antiviral, sterile packaging formats. Plastics, against this backdrop, are emerging as a perfect material for antiviral and sterile packaging. Based on its high versatility and barrier properties, plastic is anticipated to emerge as the preferred option for these packaging solutions.

Moreover, antiviral biopolymers, mainly products reinforced with specific active drug components, are anticipated to witness immense popularity owing to their eco-friendly nature and low toxicity. These products present an effective solution to reduce the contamination risk and ensure handling safety. Several companies are also betting on NO2-based sterilization technology for achieving product differentiation. The technology offers benefits of ultra-low temperature process, low pressure requirements and faster cycle times. In addition, plastic presents an ideal solution for ensuring longer shelf life of pharmaceutical products, which is slated to benefit the packaging material during the pandemic.

In support of the world’s focus on development of COVID-19 vaccine, pharmaceutical packaging market is also scaling up operations to keep pace with the ongoing efforts in the space. Companies engaged in development of COVID-19 vaccines are signing agreements with packaging companies for manufacturing syringes and vials to package COVID-19 vaccine.

Moderna for instance announced a collaborative deal with Catalent in June 2020 for providing vial filling and packaging for initial batch of 100 million doses of vaccine from its US facility in Indiana. The company is expected to produce around 500 million to 1 billion doses annually, starting in 2021 from its US-based production facility, through a strategic partnership with Lonza, enhancing the need for packaging solutions. Presently, around 142 experimental vaccines are under studies, focusing on diverse technologies, to efficiently assess clinical outcomes across board.

Irrespective of the diverse platforms, the development haste is all set to augur well for the production of vaccine in the near term. About 13 vaccines have entered human trials to test the safety and efficacy of the vaccine on healthy volunteers, while 129 are in pre-clinical animal trial studies.

Moderna, AstraZeneca, CanSino Biologics, and Pfizer are expected to be released in the first wave during second half of 2020 and first quarter of 2021. The second wave will see Johnson & Johnson, GlaxosmithKline/Sanofi in the second half of 2021.

The production of vaccines would start even before the regulatory approval from third quarter of 2020. Commercial availability of the vaccine would start between fourth quarter 2020 to early 2021.

Scaling up manufacturing facilities, growing global efforts in terms of non-profit public-private partnerships ensuring equitable access to vaccine supplies, greater international collaboration for mapping safety data and vaccination protocols, and strategic financing are all set to boost the prospects of successful development and utilization of COVID-19 vaccine in the near term.

Competitors identified in this market include, among others:

• Accutek Packaging Equipment Companies, Inc.
• ACG Worldwide Pvt., Ltd.
• IMA SpA
• Korber AG
• Marchesini Group SpA
• Mg2 Srl
• MULTIVAC Sepp Haggenmuller SE & Co. KG
• Optima Packaging Group GmbH
• Robert Bosch GmbH
• Romaco Pharmatechnik GmbH
• Uhlmann Group
• Vanguard Pharmaceutical Machinery, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• COVID-19 Impact on Pharmaceutical Packaging Market
• COVID-19 to Restructure the Pharmaceutical Supply Chain Management
• Pharmaceutical Companies Devise Innovative Strategies for Streamlining Supply Chain Networks
• Pharmaceutical Packaging Players Gear Up with Sterile, Antiviral Packaging to Deal with COVID-19 Challenge
• Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand for Packaging Products, Propel Growth in Packaging Equipment
• A Prelude to Pharmaceutical Packaging
• An Introduction to Pharmaceutical Packaging Equipment
• Global Pharmaceutical Packaging Equipment Market: Prospects & Outlook
• Advancements in Pharmaceutical & Biopharmaceutical Industries Fuel Growth Packaging Equipment Market
• Primary Packaging Equipment Segment Leads Market
• Liquids Packaging Equipment Dominates Global Market
• Europe Continues to Rein Global Pharmaceutical Packaging Equipment Market
• Competition
• Packaging Equipment Providers Rise Up to Address Evolving Needs and Challenges Faced by Pharmaceutical Industry

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Strong Rise in Pharmaceutical Sales to Drive Demand for Glass Packaging Solutions
• Rapid Growth of Generic Drugs Drives Demand for Pharma Packaging Equipment
• Increasing Significance of Biologic Drugs Fuels Innovations in Packaging and Delivery Techniques, Supporting Demand for Packaging Equipment
• Increasing Sales of OTC Drugs Presents an Opportunity for Pharma Packaging Equipment Makers
• Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
• Market Poised to Benefit from the Rapid Growth of Pharmaceutical Contract Manufacturing Activity
• Contract Packaging Trend Augurs Well for the Pharma Packaging Equipment Market
• With Emerging Economies Emerging as Hubs of Pharma Manufacturing Activity, Growth Potential in Store for Equipment Companies
• Trends in Pharmaceutical Sector Drive the Need for Collaboration between Industry and Equipment Providers
• OEE Makes Way into the Pharma Sector
• Serialization Drives New Design Developments in Pharma Sector
• Blister Packaging: The Mainstay of Pharmaceutical Packaging
• Blister Packaging on Rise in the Pharmaceutical Sector
• Increasing Use of Blow/Fill/Seal Technology in Pharmaceutical Packaging Applications
• Demand Remains Consistent for Aseptic & Sealing Equipment in Pharmaceutical Industry
• Rise of Smart Packaging in Pharmaceutical Sector Influences Equipment Demand
• Demand Rises for Integrated and Flexible Packaging Equipment in Pharma Industry
• Automated Packaging Equipment Support Market Growth
• Labeling & Serialization Equipment Segment Benefits from Increased Focus on Preventing Counterfeiting of Drugs
• Equipment for Small Batch Production & Research Purposes Find Favor
• Evolving Technologies and Trends Impact Growth in Pharmaceutical Manufacturing & Packaging Equipment Market
• Shift Towards Specialized Therapies and Biopharmaceuticals Influences Market
• Rising Demand for Equipment with Complex, Integrated Capabilities
• Equipment Manufacturers Striving to Address Major Industry Challenges
• Increasing Use of Robots
• Evolving and Complex Drug Formulations Lead to Packaging Equipment Innovations
• Biopharmaceuticals Drive Innovations in Pharma Packaging Equipment Market
• Pharmaceutical Packaging Equipment Vendors Bet on Innovations to Stay Afloat
• Persistent Increase in Pharmaceutical R&D Bodes Well for Packaging Equipment Manufacturers
• Strict Regulatory Standards for Packaging & Need to Eliminate Counterfeit Products Influence Equipment Development
• Regulatory Uncertainty Makes Compliance Challenging
• Inclination Towards Refurbished Equipment Emerges as a Threat to Pharma Packaging Equipment Market

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

• GEOGRAPHIC MARKET ANALYSIS
• UNITED STATES
• Pharmaceutical Packaging Emerges as a Promising Category in the US Packaging Machinery Market
• Validation Compliance of Machinery to Gain Importance
• Market Analytics
• CANADA
• JAPAN
• CHINA
• China’s Drug Contract Manufacturing Augurs Well for Packaging Equipment Makers
• Market Analytics
• EUROPE
• Europe Pharmaceutical Packaging Market: A Prelude
• Market Analytics
• FRANCE
• GERMANY
• ITALY
• UNITED KINGDOM
• SPAIN
• RUSSIA
• REST OF EUROPE
• ASIA-PACIFIC
• AUSTRALIA
• INDIA
• Indian Pharmaceutical Equipment Market: Poised for Growth
• India’s Emergence as a Hub of Pharmaceutical Manufacturing Supports Growth in Packaging Equipment Market
• Market Analytics
• SOUTH KOREA
• REST OF ASIA-PACIFIC
• LATIN AMERICA
• BRAZIL
• MEXICO
• REST OF LATIN AMERICA
• MIDDLE EAST
• AFRICA

IV. COMPETITION

• Total Companies Profiled: 98

For more information about this report visit https://www.researchandmarkets.com/r/yi89u7

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900